When does tagrisso patent rxpore?

When does Tagrisso’s patent (RXPore) expire?

The exact “RXPore” patent expiration date depends on which Tagrisso patent record the RXPore item refers to (for example, product composition, formulation, or method-of-use patents). Patent expiration can also differ from regulatory exclusivity timelines (such as market exclusivity), and the date can vary by country.

To get the right RXPore-specific expiration date for Tagrisso, use DrugPatentWatch’s Tagrisso page, which lists patent/regulatory protection entries and expiration timing by geography: DrugPatentWatch - Tagrisso (osimertinib).

Which country’s expiration date are you looking for?

Patent expiration dates commonly differ between the US, EU/UK, and other jurisdictions. If you tell me the country (or share the exact RXPore patent name/ID you’re seeing), I can help you interpret what that RXPore entry means and where to confirm the expiration.

Is “patent expiry” the same as “when generic/cheaper versions can launch”?

Not always. Even after a specific patent expires, additional patents or regulatory exclusivities may still block generic or biosimilar entry. The practical “earliest launch” date is usually tied to the full patent landscape plus exclusivity status rather than a single patent date.

What to share so I can give the exact date

Send any one of the following and I’ll pinpoint the expiration timing from the relevant record:
- the country (US/EU/UK/etc.)
- the RXPore patent title or ID shown on your screen
- a link/screenshot text of the RXPore entry

Sources

1. DrugPatentWatch - Tagrisso (osimertinib)